Nationwide Assessment of Cardiovascular Risk Factors: in Chinese Patients With Type 2 Diabetes

NCT01128205 | Completed

• 1 other identifier: CCMR-302-3B
• Study Type: observational
• Target: 25,000
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of this study is to evaluate the level of control of cardiovascular disease risk factors, including blood pressure, blood lipid, and blood glucose, in out patients with type 2 DM in 6 representative regions in China: Northeast, North, East, South, Southwest and Northwest, measured by,

1. 1.Proportion of patients reaching adequate control of blood glucose
2. 2.Proportion of patients reaching adequate control of blood glucose and blood pressure, or blood glucose and blood lipid
3. 3.Proportion of patients reaching adequate control of all 3Bs, i.e. blood glucose, blood pressure, and blood lipid.

Conditions

Type 2 Diabetes

Keywords

diabetes; cardiovascular risk factors; blood pressure; blood lipid; blood glucose

Outcome Measures

Primary Outcomes (1)

• The proportion adequate control of blood glucose, blood glucose and blood pressure or blood glucose and blood lipid, and blood glucose, blood pressure and blood lipid.

  From the time of enrollment to within 30 day of enrollment

Study Arms (1)

Diagnosed for 6 months or more

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Chinese type 2 diabetic out-patients with diagnosis for 6 months or more

You may qualify if:

• Outpatients with confirmed type 2 DM (According to ADA criteria) at least 6 month prior to the study visit;
• At least 18 years or older;
• Patients who are due and willing to receive a fasting blood testing within 7 days due to his/her underlying diseases, as determined by the investigator; or patients who have adequate blood test results obtained within 30 days;
• Patients who are willing to sign consent form and are able to complete the questionnaires.

You may not qualify if:

• Patients with type 1 DM;
• Pregnant or breast feeding women;
• Patients who are participating in any other clinical studies, including any questionnaire-based study, any interventional study (even diet/counseling based intervention), or any clinical trial in which any medication (including Chinese herbal medications) are administered.

Sponsors & Collaborators

• China Cardiometabolic Registries: lead
• Merck Sharp & Dohme LLC: collaborator
• China Gerontological Society: collaborator
• VitalStrategic Research Institute: collaborator

Study Sites (1)

Peking Univresity People's Hospital

Beijing, China

Location

Related Publications (2)

• Ji Q, Chai S, Zhang R, Li J, Zheng Y, Rajpathak S. Prevalence and co-prevalence of comorbidities among Chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database. Front Endocrinol (Lausanne). 2024 Jun 11;15:1362433. doi: 10.3389/fendo.2024.1362433. eCollection 2024.

  PMID: 38919489 DERIVED

• Cai X, Ji L. Generalizability of the Results of Cardiovascular Outcome Trials of Glucagon-Like Peptide 1 Receptor Agonists in Chinese Patients with Type 2 Diabetes Mellitus. Diabetes Ther. 2021 Jul;12(7):1861-1870. doi: 10.1007/s13300-021-01079-x. Epub 2021 May 28.

  PMID: 34047959 DERIVED

Related Links

• Related Info

MeSH Terms

Conditions

Diabetes Mellitus, Type 2; Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Study Officials

• Linong Ji, MD

  Peking University People's Hospital

  PRINCIPAL INVESTIGATOR

• Dayi Hu, MD

  Peking University People's Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: NETWORK

Study Record Dates

• First Submitted: May 19, 2010
• First Posted: May 21, 2010
• Study Start: June 1, 2010
• Primary Completion: June 1, 2011
• Study Completion: June 1, 2011
• Last Updated: June 15, 2011

Record last verified: 2010-08

Locations

CN (1)